Sun Pharma launches FluGuard for covid treatment at rs.35 per tablet.
Tue, Aug 04, 2020, 06:48 PM
Sun Pharma has launched Favipiravir at Rs 35 per tablet for the potential treatment of patients who have been facing mild to moderate symptoms of Covid-19 disease. It would be the cheapest in the market. The company has put a brand name FluGuard to it. Favipiravir is the oral anti-viral treatment approved in India.
As there is an immediate need to provide more treatment options to COVID-19 patients in an alarming situation, the need is felt. The drug is now available to more and more patients, thereby reducing their financial burden.